Publicações Científicas 2022 - Janeiro a Abril

 

1. Rohr P, Campanelli Dos Santos I, van Helvoort Lengert A, Alves de Lima M, Manuel Reis R, Barbosa F, Jr., et al. Absolute telomere length in peripheral blood lymphocytes of workers exposed to construction environment. Int J Environ Health Res. 2022:1-9. doi: 10.1080/09603123.2022.2066069

 

2. Schmid S, Jiang M, Brown MC, Fares A, Garcia M, Soriano J, et al. Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data. Cancer Epidemiol Biomarkers Prev. 2022. doi: 10.1158/1055-9965.Epi-21-0747

 

3. Datorre JG, de Carvalho AC, Dos Reis MB, Dos Reis M, Matsushita M, Santos F, et al. Accuracy and Clinical Relevance of Intra-Tumoral Fusobacterium nucleatum Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Tissue by Droplet Digital PCR (ddPCR) in Colorectal Cancer. Diagnostics (Basel). 2022;12(1). doi: 10.3390/diagnostics12010114

 

4. Syrjänen K. Accuracy of Serum Biomarker Panel (GastroPanel(®)) in the Diagnosis of Atrophic Gastritis of the Corpus. Systematic Review and Meta-analysis. Anticancer Res. 2022;42(4):1679-96. doi: 10.21873/anticanres.15645

 

5. Baiocchi G, Ribeiro R, Dos Reis R, Lopes A, Zanvettor PH. ASO Author Reflections: Minimally Invasive Radical Hysterectomy in Cervical Cancer: A Brazilian Multicentric Cohort Study (CIRCOL). Ann Surg Oncol. 2022;29(2):1161-2. doi: 10.1245/s10434-021-10875-5

 

6. Zampieri FG, Machado FR, Biondi RS, Freitas FGR, Veiga VC, Figueiredo RC, et al. Association Between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the Balanced Solutions in Intensive Care (BaSICS) Study. Am J Respir Crit Care Med. 2022. doi: 10.1164/rccm.202111-2484OC

 

7. Berardinelli GN, Durães R, Mafra da Costa A, Bragagnoli A, Antônio de Oliveira M, Pereira R, et al. Association of microsatellite instability (MSI) status with the 5-year outcome and genetic ancestry in a large Brazilian cohort of colorectal cancer. Eur J Hum Genet. 2022. doi: 10.1038/s41431-022-01104-y

 

8. Ferreira J, Carneiro AL, Vila I, Cunha C, Silva CR, Longatto-Filho A, et al. Association of Skeletal Muscle and Cardiovascular Risk Factors in Patients with Lower Extremity Arterial Disease. Ann Vasc Surg. 2022;80:223-34. doi: 10.1016/j.avsg.2021.08.037

 

9. Valadão M, Cesar D, Véo CAR, Araújo RO, do Espirito Santo GF, Oliveira de Souza R, et al. Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer. J Surg Oncol. 2022;125(2):194-216. doi: 10.1002/jso.26676

 

10. Shafaee MN, Silva LR, Ramalho S, Doria MT, De Andrade Natal R, Cabello V, et al. Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil. Oncologist. 2022. doi: 10.1093/oncolo/oyac050

 

11. Costa AMD, Hernandes ICP, Weiderpass E, Soerjomataram I, Fregnani J. Cancer statistics over time in northwestern São Paulo State, Brazil: incidence and mortality. Cancer Epidemiol Biomarkers Prev. 2022. doi: 10.1158/1055-9965.Epi-21-0842

 

12. Hochhegger B, Camargo S, da Silva Teles GB, Chate RC, Szarf G, Guimarães MD, et al. Challenges of Implementing Lung Cancer Screening in a Developing Country: Results of the Second Brazilian Early Lung Cancer Screening Trial (BRELT2). JCO Glob Oncol. 2022;8:e2100257. doi: 10.1200/go.21.00257

 

13. de Oliveira Faria S, Simões Lima GA, Lopes Carvalho A, Nader Marta G, Howell D, Eluf-Neto J. Clinically significant changes in health-related quality of life in head and neck cancer patients following intensive nutritional care during radiotherapy. Eur J Oncol Nurs. 2022;56:102065. doi: 10.1016/j.ejon.2021.102065

 

14. Eskelinen M, Meklin J, Guimarães DP, Selander T, Tiusanen T, Syrjänen K, et al. The ColonView (CV) Quick Test for Fecal Occult Blood Shows Significantly Higher Diagnostic Accuracy in Detecting Distal than Proximal Colorectal Cancer. Anticancer Res. 2022;42(4):1879-91. doi: 10.21873/anticanres.15664

 

15. de Faria FW, Valera ET, Macedo C, Azevedo EF, Vieira AGS, Martins GE, et al. Comment on: Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents. Pediatr Blood Cancer. 2022:e29650. doi: 10.1002/pbc.29650

 

16. Gomes INF, da Silva-Oliveira RJ, da Silva LS, Martinho O, Evangelista AF, van Helvoort Lengert A, et al. Comprehensive Molecular Landscape of Cetuximab Resistance in Head and Neck Cancer Cell Lines. Cells. 2022;11(1). doi: 10.3390/cells11010154

 

17. Silva DFD, Paiva CE, Paiva BSR. Cross-cultural adaptation and translation of the Pediatric Intensive Care Unit-Quality of Dying and Death into Brazilian Portuguese. Rev Bras Ter Intensiva. 2022;33(4):592-9. doi: 10.5935/0103-507x.20210086

 

18. Andres MP, Souza C, Villaescusa M, Vieira M, Abrao MS. The current role of robotic surgery in endometriosis management. Expert Rev Endocrinol Metab. 2022;17(1):63-73. doi: 10.1080/17446651.2022.2031976

 

19. Paiva RL, de Figueiredo MAZ, Cherubini K, Da Silva VD, Salum FG. Cytological Screening Model of Normal Oral Mucosa Exposed to Carcinogens: A Pilot Study. Acta Cytol. 2022;66(2):114-23. doi: 10.1159/000519877

 

20. Poma MAM, Ribeiro Junior HL, Costa EA, Paier CRK, Brasil LL, Lima LB, et al. Effect of CYB2B6 (c.516G>T), CYP2C9 (c.1075A>C) and UGT1A9 (c.98T>C) polymorphisms on propofol pharmacokinetics in patients submitted to colonoscopy: a cohort study. Postgrad Med J. 2022. doi: 10.1136/postgradmedj-2021-141375

 

21. Casali BC, Gozzer LT, Baptista MP, Altei WF, Selistre-de-Araújo HS. The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro. Int J Mol Sci. 2022;23(3). doi: 10.3390/ijms23031745

 

22. Silva NMF, Carvalho IRA, Lopes LP, Menezes TM, Guandalini VR, Capuzzo RC. Evolution of Nutritional Status in Patients with Advanced Head and Neck Cancer Undergoing Surgical Treatment or Organ Preservation Protocol. Nutr Cancer. 2022;74(3):852-9. doi: 10.1080/01635581.2021.1931367

 

23. Leite CM, Honorato J, Martin A, Silveira RG, Colombari FM, Amaral JC, et al. Experimental and Theoretical DFT Study of Cu(I)/N,N-Disubstituted-N’-acylthioureato Anticancer Complexes: Actin Cytoskeleton and Induction of Death by Apoptosis in Triple-Negative Breast Tumor Cells. Inorg Chem. 2022;61(1):664-77. doi: 10.1021/acs.inorgchem.1c03389

 

24. Munari FF, Sichero L, Carloni AC, Lacerda CF, Nunes EM, de Oliveira ATT, et al. Frequency of Human Papillomavirus Detection in Chagasic Megaesophagus Associated or Not with Esophageal Squamous Cell Carcinoma. Pathobiology. 2022;89(1):29-37. doi: 10.1159/000518697

 

25. Fatobene G, Cordeiro A, Mariano L, Silva M, Bouzas L, Hamerschlak N, et al. GVHD treatment with extracorporeal photopheresis in Brazil: a national survey. Hematol Transfus Cell Ther. 2022. doi: 10.1016/j.htct.2021.11.018

 

26. Preto DD, Paiva BSR, Hui D, Bruera E, Paiva CE. HAprog: a new prognostic application to assist oncologists in routine care. J Pain Symptom Manage. 2022. doi: 10.1016/j.jpainsymman.2022.02.004

 

27. Brunetti IA, Pereira PC, Oliveira DS, Silva VAO, Reis RM, Américo-Pinheiro JHP, et al. Histological Biomarkers and Protein Expression in Hyphessobrycon eques Fish Exposed to Atrazine. Water, Air, & Soil Pollution. 2022;233(3):97. doi: 10.1007/s11270-022-05569-x

 

28. Oliveira AC, Cavalcanti de Lima IC, Frez Marques VM, Alves de Araújo WH, de Campos Ferreira C. Human papillomavirus prevalence in oral and oropharyngeal squamous cell carcinoma in South America: A systematic review and meta-analysis. Oncol Rev. 2022;16(1):552. doi: 10.4081/oncol.2022.552

 

29. Oliveira AF, Tansini A, Toledo T, Balceiro R, Lee MLM, Villela N, et al. Immunophenotypic changes in juvenile myelomonocytic leukaemia after treatment with hypomethylating agent: Do they help to evaluate dept of response? Br J Haematol. 2022. doi: 10.1111/bjh.18089

 

30. Ciria R, Berardi G, Alconchel F, Briceño J, Choi GH, Wu YM, et al. The impact of robotics in liver surgery: A worldwide systematic review and short-term outcomes meta-analysis on 2,728 cases. J Hepatobiliary Pancreat Sci. 2022;29(2):181-97. doi: 10.1002/jhbp.869

 

31. Cevik L, Landrove MV, Aslan MT, Khammad V, Garagorry Guerra FJ, Cabello-Izquierdo Y, et al. Information theory approaches to improve glioma diagnostic workflows in surgical neuropathology. Brain Pathol. 2022:e13050. doi: 10.1111/bpa.13050

 

32. Guimarães YM, Godoy LR, Longatto-Filho A, Reis RD. Management of Early-Stage Cervical Cancer: A Literature Review. Cancers (Basel). 2022;14(3). doi: 10.3390/cancers14030575

 

33. Zapaterini JR, Fonseca ARB, Bidinotto LT, Colombelli KT, Rossi ALD, Kass L, et al. Maternal Low-Protein Diet Deregulates DNA Repair and DNA Replication Pathways in Female Offspring Mammary Gland Leading to Increased Chemically Induced Rat Carcinogenesis in Adulthood. Front Cell Dev Biol. 2021;9:756616. doi: 10.3389/fcell.2021.756616

 

34. Setlai BP, Hull R, Reis RM, Agbor C, Ambele MA, Mulaudzi TV, et al. MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma. Genes. 2022;13(2):244. doi:

 

35. De Marchi P, Berardinelli GN, Cavagna RO, Pinto IA, da Silva FAF, Duval da Silva V, et al. Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology. 2022;89(2):101-6. doi: 10.1159/000520023

 

36. Naakka E, Barros-Filho MC, Adnan-Awad S, Al-Samadi A, Marchi FA, Kuasne H, et al. miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands. Front Oncol. 2021;11:786150. doi: 10.3389/fonc.2021.786150

 

37. Chinoca J, Andrade DS, Mendes A, Marchi P, Prieto TG, Baldavira CM, et al. Monitoring non-small cell lung cancer progression and treatment response through hyaluronic acid in sputum. Braz J Med Biol Res. 2022;55:e11513. doi: 10.1590/1414-431X2021e11513

 

38. Brenes D, Barberan CJ, Hunt B, Parra SG, Salcedo MP, Possati-Resende JC, et al. Multi-task network for automated analysis of high-resolution endomicroscopy images to detect cervical precancer and cancer. Comput Med Imaging Graph. 2022;97:102052. doi: 10.1016/j.compmedimag.2022.102052

 

39. Altei WF, Pachane BC, Souza C, Marques MMC, Selistre-de-Araújo H. New insights into the discovery of drugs for triple-negative breast cancer metastasis. Expert Opin Drug Discov. 2022:1-12. doi: 10.1080/17460441.2022.2039619

 

40. Garcia FAO, de Andrade ES, de Campos Reis Galvão H, da Silva Sábato C, Campacci N, de Paula AE, et al. New insights on familial colorectal cancer type X syndrome. Sci Rep. 2022;12(1):2846. doi: 10.1038/s41598-022-06782-8

 

41. Shitara K, Ajani JA, Moehler M, Garrido M, Gallardo C, Shen L, et al. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature. 2022. doi: 10.1038/s41586-022-04508-4

 

42. Granja SC, Longatto-Filho A, de Campos PB, Oliveira CP, Stefano JT, Martins-Filho SN, et al. Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism. Pathobiology. 2022:1-9. doi: 10.1159/000521034

 

43. Bakulina N, Tikhonov S, Malkov V, Vorobyev S, Belyakov I, Peshkova N, et al. Non-invasive Screening of Autoimmune Atrophic Gastritis in Asymptomatic Subjects by Serological Biomarker Test (GastroPanel(®)). Anticancer Res. 2022;42(3):1517-26. doi: 10.21873/anticanres.15624

 

44. Coelho JC, de Souza Carvalho G, Chaves F, de Marchi P, de Castro G, Jr., Baldotto C, et al. Non-Small-Cell Lung Cancer With CNS Metastasis: Disparities From a Real-World Analysis (GBOT-LACOG 0417). JCO Glob Oncol. 2022;8:e2100333. doi: 10.1200/go.21.00333

 

45. Stelet VN, Cita RF, Mendes MF, Romero M, Abdelhay E. The novel HLA-DQB1*05:240 allele was likely generated by recombination between DQB1*05:01 and DQB1*03:02. Hla. 2022;99(2):144-5. doi: 10.1111/tan.14418

 

46. Viani GA, Gouveia AG, Matsuura FK, Jacinto AA, Moraes FY. Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials. Radiother Oncol. 2022. doi: 10.1016/j.radonc.2022.01.032

 

47. Tukiama R, Vieira RAC, Moura ECR, Oliveira AGC, Facina G, Zucca-Matthes G, et al. Oncologic safety of breast reconstruction with autologous fat grafting: A systematic review and meta-analysis. Eur J Surg Oncol. 2022;48(4):727-35. doi: 10.1016/j.ejso.2021.12.017

 

48. Santos Neto MFD, Paiva CE, de Lima C, Ribeiro AG, Paiva BSR. Oncology palliative care: access barriers: bibliometric study. BMJ Support Palliat Care. 2022. doi: 10.1136/bmjspcare-2021-003387

 

49. Baiocchi G, Ribeiro R, Dos Reis R, Falcao DF, Lopes A, Costa RLR, et al. Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study. Ann Surg Oncol. 2022;29(2):1151-60. doi: 10.1245/s10434-021-10813-5

 

50. Salvo G, Ramirez PT, Leitao MM, Cibula D, Wu X, Falconer H, et al. Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study. Am J Obstet Gynecol. 2022;226(1):97.e1-.e16. doi: 10.1016/j.ajog.2021.08.029

 

51. Agusti N, Zorrilla Vaca A, Segarra-Vidal B, Iniesta MD, Mena G, Pareja R, et al. Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program. Int J Gynecol Cancer. 2022. doi: 10.1136/ijgc-2021-003244

 

52. van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, et al. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. J Cancer Surviv. 2022. doi: 10.1007/s11764-021-01160-1

 

53. Valentino TCO, Paiva CE, Julião M, Paiva BSR. Place of death among Brazilian patients with cancer: preferences and associated factors. BMJ Support Palliat Care. 2022. doi: 10.1136/bmjspcare-2022-003666

 

54. Canzian F, Piredda C, Macauda A, Zawirska D, Andersen NF, Nagler A, et al. A polygenic risk score for multiple myeloma risk prediction. Eur J Hum Genet. 2022;30(4):474-9. doi: 10.1038/s41431-021-00986-8

 

55. Lorenzi NPC, Termini L, Ferreira-Filho ES, Nunes RAL, Silva GAF, Lepique AP, et al. A positive HPV test with positive p16/Ki-67 double staining in self-sampled vaginal material is an accurate tool to detect women at risk for cervical cancer. Cancer Cytopathol. 2022;130(1):41-54. doi: 10.1002/cncy.22498

 

56. Lo AC, Major A, Super L, Appel B, Shankar A, Constine LS, et al. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW). Leuk Lymphoma. 2022:1-4. doi: 10.1080/10428194.2022.2053533

 

57. Pires RC, Carvalho R, Gama RR, Carvalho AL, Santos CR, Capuzzo RC. Progressive Increase Trend in HPV-Related Oropharyngeal Squamous Cell Carcinoma in Brazil. Int Arch Otorhinolaryngol. 2022;26(1):e132-e6. doi: 10.1055/s-0041-1730297

 

58. Faustino FLC, Altei WF, Canton HP, Morato L, de Paula L, Salvador GB, et al. RAdiotherapy for Prostate cancer using HYpofractionation Directed by UltraSound (RAPHYDUS): a Brazilian public health care system study. Pract Radiat Oncol. 2022. doi: 10.1016/j.prro.2022.04.001

 

59. Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genet Med. 2022;24(1):119-29. doi: 10.1016/j.gim.2021.08.016

 

60. Matos LL, Capuzzo RC, Pedruzzi PAG, Farias T, de Farias JWM, Chone CT, et al. Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real-world experience in Brazil. Head Neck. 2022. doi: 10.1002/hed.27061

 

61. Baiocchi G, Andrade C, Ribeiro R, Moretti-Marques R, Tsunoda AT, Alvarenga-Bezerra V, et al. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial). Int J Gynecol Cancer. 2022. doi: 10.1136/ijgc-2022-003378

 

62. Moreno DA, da Silva LS, Zanon MF, Bonatelli M, de Paula FE, de Medeiros Matsushita M, et al. Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study. J Neurooncol. 2022. doi: 10.1007/s11060-022-03965-1

 

63. Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, et al. Survival with Cemiplimab in Recurrent Cervical Cancer. N Engl J Med. 2022;386(6):544-55. doi: 10.1056/NEJMoa2112187

 

64. Takahashi P, Xavier DJ, Lima J, Evangelista AF, Collares CVA, Foss-Freitas MC, et al. Transcript Expression Profiles and MicroRNA Regulation Indicate an Upregulation of Processes Linked to Oxidative Stress, DNA Repair, Cell Death, and Inflammation in Type 1 Diabetes Mellitus Patients. J Diabetes Res. 2022;2022:3511329. doi: 10.1155/2022/3511329

 

65. Llera AS, Abdelhay E, Artagaveytia N, Daneri-Navarro A, Müller B, Velazquez C, et al. The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients. Front Oncol. 2022;12:835626. doi: 10.3389/fonc.2022.835626

 

66. Mançano BM, Dos Reis MB, Moreno DA, de Paula FE, de Almeida Junior CR, Cavalcante CEB, et al. A Unique Case Report of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with TPR-NTRK1 Fusion Treated with Larotrectinib. Pathobiology. 2022:1-8. doi: 10.1159/000521253

 

67. Vieira R, de Oliveira LCN, Ching AW, de Oliveira-Junior I. Use of Double Myocutaneous Flap after Extended Resection of Locally Advanced Ulcerated Breast Carcinoma. Plast Reconstr Surg Glob Open. 2022;10(2):e4133. doi: 10.1097/gox.0000000000004133

 

68. Braz DC, Neto MP, Shimizu FM, Sá AC, Lima RS, Gobbi AL, et al. Using machine learning and an electronic tongue for discriminating saliva samples from oral cavity cancer patients and healthy individuals. Talanta. 2022;243:123327. doi: 10.1016/j.talanta.2022.123327

 

69. Valentino TOC, de Oliveira MA, Paiva CE, Paiva BSR. Where do Brazilian cancer patients prefer to die? Agreement between patients and caregivers. J Pain Symptom Manage. 2022. doi: 10.1016/j.jpainsymman.2022.03.015

 

 

 

Grupos de Pesquisas

Calendário de Eventos

02 e 03 de Setembro | 2022

CPOM

VIII International Symposium on Translational Oncology

Seguindo com sua missão de formar pesquisadores e disseminar dentre estes e dentre oncologistas, residentes, alunos de pós-graduação e demais profissionais de saúde os principais temas oncológicos da atualidade, o Instituto de Ensino e Pesquisa do Hospital do Câncer de Barretos (IEP) realizará o VIII Simpósio Internacional de Oncologia Translacional do Hospital de Câncer de Barretos.